Schedule 13G ownership disclosure
Immunic Inc
Common Stock, $0.0001 par value · CUSIP: 4525EP101
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AVIDITY PARTNERS MANAGEMENT LP
Shares: 6,041,059.00 · Class: 6.6%
- AVIDITY PARTNERS MANAGEMENT (GP) LLC
Shares: 6,041,059.00 · Class: 6.6%
- AVIDITY CAPITAL PARTNERS FUND (GP) LP
Shares: 6,041,059.00 · Class: 6.6%
- AVIDITY CAPITAL PARTNERS (GP) LLC
Shares: 6,041,059.00 · Class: 6.6%
- AVIDITY PRIVATE MASTER FUND I LP
Shares: 4,699,532.00 · Class: 5.2%
- MICHAEL GREGORY
Shares: 6,041,059.00 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-003220
- Form type
- SCHEDULE 13G/A
- Filer
- Avidity Partners Management LP
- CIK
- CIK 1791827
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership